<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04977882</url>
  </required_header>
  <id_info>
    <org_study_id>Registro sperimentazioni XX.21</org_study_id>
    <nct_id>NCT04977882</nct_id>
  </id_info>
  <brief_title>Abdominal Drainage vs Postoperative Antibiotico-prophylaxis vs Control in Laparoscopic Right Hemicolectomy With Intracorporeal Anastomosis for Right Colon Cancer</brief_title>
  <official_title>Abdominal Drainage vs Postoperative Antibiotico-prophylaxis vs Control in Laparoscopic Right Hemicolectomy With Intracorporeal Anastomosis for Right Colon Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rome Tor Vergata</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rome Tor Vergata</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Monocentric pilot prospective randomized study with 3 cohorts: abdominal drainage vs&#xD;
      postoperative antibioticoprophylaxis vs none in patients undergoing laparoscopic right&#xD;
      hemicolectomy with introcorporeal anastomosis for right colon cancer&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">January 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>C-Reactive Proteine</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>measured mg/L in I and III POD</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>White blood cell</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>measured thousands/mL in I and III POD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procalcitonine</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>measured ng/ml in III and V POD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of hospitalization</measure>
    <time_frame>90 days postoperatively</time_frame>
    <description>number of days of hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission rate</measure>
    <time_frame>90 days postoperatively</time_frame>
    <description>rate of hospital readmission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>90 days postoperatively</time_frame>
    <description>postoperative mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical site infection rate</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>postoperative wound infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anastomotic leak rate</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>postoperative Ileocolic anastomotic leakage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance to liquid diet</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>time to clear fluid tolerance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance to solid diet</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>time to light diet tolerance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first flatus</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>Time to first flatus postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first evacuation</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>Time to first evacuation postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>need of abdomen CTscan rate</measure>
    <time_frame>30 days postoperatively</time_frame>
    <description>need of abdomen CTscan</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Colon Cancer</condition>
  <arm_group>
    <arm_group_label>Abdominal drainage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>19 Fr abdominal drainage placed intraoperatevely in right paracolic gutter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Postoperative antibiotico-prophylaxis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>postoperative antibiotico-prophylaxis with Ceftriaxone 2gr and Metronidazole 1.5gr</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No drainage nor postoperative antibiotico-prophylaxis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>abdominal drainage</intervention_name>
    <description>19 Fr abdominal drainage placed intraoperatively in right colic gutter</description>
    <arm_group_label>Abdominal drainage</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Postoperative antibiotico-prophylaxis</intervention_name>
    <description>Ceftriaxone 2 gr and Metronidazole 1.5 gr per day for 2 days postoperatively</description>
    <arm_group_label>Postoperative antibiotico-prophylaxis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Right colon cancer&#xD;
&#xD;
          -  Intracorporeal anastomosis&#xD;
&#xD;
          -  Laparoscopic surgery&#xD;
&#xD;
          -  Elective surgery&#xD;
&#xD;
          -  informed consent signed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  below 18 years old&#xD;
&#xD;
          -  IBD&#xD;
&#xD;
          -  ASA IV&#xD;
&#xD;
          -  T4b&#xD;
&#xD;
          -  Metastatic disease&#xD;
&#xD;
          -  Preoperative steroids&#xD;
&#xD;
          -  Conversion to open surgery&#xD;
&#xD;
          -  Emergency surgery&#xD;
&#xD;
          -  concomitant major operation&#xD;
&#xD;
          -  preoperative infective status&#xD;
&#xD;
          -  benign disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 15, 2021</study_first_submitted>
  <study_first_submitted_qc>July 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2021</study_first_posted>
  <last_update_submitted>July 25, 2021</last_update_submitted>
  <last_update_submitted_qc>July 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rome Tor Vergata</investigator_affiliation>
    <investigator_full_name>Giuseppe Sigismondo Sica</investigator_full_name>
    <investigator_title>Head of Minimally Invasive Surgery Unit</investigator_title>
  </responsible_party>
  <keyword>intracorporeal anastomosis</keyword>
  <keyword>right hemicoletomy</keyword>
  <keyword>colon cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

